What structured clerking template should be used for an older adult patient with cerebral atrophy referred to a neurologist?

Clerking Template for Cerebral Atrophy Neurology Referral

Use a structured, multi-tiered assessment framework that systematically evaluates cognitive-behavioral syndrome, functional status, neuropsychiatric symptoms, and underlying etiology through standardized instruments and informant-based history. 1

Essential History Components

Patient AND Informant Interview (Both Required)

You must obtain collateral history from a reliable informant—this is not optional 1. Structure your assessment around four mandatory domains:

1. Cognitive Changes

• Memory (short-term, long-term, working memory)
• Executive function (planning, organization, judgment)
• Language (word-finding, comprehension)
• Visuospatial abilities
• Attention and processing speed

2. Functional Decline 1

• Basic ADLs: Bathing, dressing, toileting, transferring, feeding, continence
• Instrumental ADLs: Medication management, financial management, cooking, shopping, transportation, housekeeping, telephone use
• Document specific examples of decline, not just general statements

3. Neuropsychiatric Symptoms 1

• Mood changes (depression, anxiety, apathy)
• Behavioral changes (agitation, aggression, disinhibition)
• Personality changes (often the earliest sign) 2
• Psychotic symptoms (hallucinations, delusions)
• Sleep pattern changes 2

4. Motor and Sensory Function 1

• Gait and balance problems (prodromal sign, not just "risk factor") 2
• Parkinsonism
• Falls history
• Sensory deficits

Risk Factors (Actually Prodromal Signs) 1, 2

Document what are traditionally called "risk factors" but recognize these may represent early cerebral deterioration:

• Declining blood pressure 2
• Weight loss and muscle wasting 2
• Falling cholesterol levels 2
• Vascular risk factors (hypertension, diabetes, hyperlipidemia, smoking)
• Family history of dementia
• Educational level and occupational history
• Head trauma history

Cognitive Assessment Tools

For Initial Screening (5 minutes):

• Mini-Cog (sensitivity 76%, specificity 89%) - validated across diverse populations, multiple languages available 3
• Administer this first; any trained team member can perform it

For Comprehensive Assessment (10-15 minutes):

• Montreal Cognitive Assessment (MoCA) 3
• Kokmen Short Test of Mental Status 3
• Saint Louis University Mental Status Examination 3

Critical caveat: Test performance is affected by native language, education level, and age—interpret accordingly 3. A single test cannot diagnose; it indicates need for further evaluation 3.

Physical Examination

Dementia-Focused Neurologic Examination 1

• Mental status: Attention, orientation, language, praxis, visuospatial function
• Cranial nerves: Especially visual fields, eye movements, facial symmetry
• Motor: Tone, strength, involuntary movements, gait analysis
• Sensory: Proprioception, vibration (peripheral neuropathy assessment)
• Reflexes: Deep tendon reflexes, primitive reflexes (frontal release signs)
• Cerebellar: Coordination, balance, tandem gait
• Gait assessment: Speed, stability, turning, dual-task performance

Additional Screening 3

• Depression: PHQ-2 or PHQ-9 (depression mimics and coexists with dementia)
• Delirium: Confusion Assessment Method (CAM) if acute changes present

Diagnostic Workup

Tier 1 Laboratory Studies (Obtain in ALL patients) 1

• Complete blood count
• Comprehensive metabolic panel
• Thyroid-stimulating hormone
• Vitamin B12
• Consider: Folate, RPR/VDRL (if risk factors present)

Structural Neuroimaging (Mandatory) 1

MRI is preferred; if unavailable or contraindicated, obtain CT 1

Assess for:

• Atrophy patterns: Medial temporal lobe atrophy (MTA score ≥2 indicates neurodegeneration) 4
• Cerebral small vessel disease markers 4:
  • White matter hyperintensities (WMH)
  • Lacunes
  • Cerebral microbleeds
• Structural lesions (tumors, subdural hematomas, normal pressure hydrocephalus)

Important: Patients with both MTA and significant WMH show the highest neurofilament light chain levels, indicating combined pathology 4. Document both independently.

Establish Shared Goals and Capacity 1

Patient-Centered Communication Framework

Before proceeding with extensive testing:

1. Assess understanding and appreciation of cognitive changes (does patient recognize symptoms apply to them?)
2. Establish shared goals for the evaluation with patient and care partner
3. Assess decision-making capacity for the evaluation process itself
4. Maintain ongoing dialogue throughout evaluation about understanding of findings 1

This is not a one-time conversation—reassess understanding at each stage 1.

Diagnostic Formulation Structure 1

Your final assessment should address three tiers:

1. Overall level of impairment: Normal cognition, subjective cognitive decline, mild cognitive impairment, or dementia
2. Cognitive-behavioral syndrome: Amnestic, dysexecutive, behavioral variant, language-predominant, visuospatial, etc.
3. Likely cause(s) and contributing factors: Alzheimer's disease, vascular dementia, mixed pathology, Lewy body dementia, frontotemporal dementia, etc.

Common Pitfalls to Avoid

• Don't rely on patient history alone—informant input is essential and often reveals deficits the patient minimizes 1
• Don't interpret declining blood pressure, weight loss, or cholesterol as "risk factors"—these are prodromal signs of cerebral deterioration 2
• Don't assume cognitive impairment is the first symptom—personality changes, balance problems, and sleep disturbances often precede memory complaints 2
• Don't use cognitive test scores in isolation—consider education, language, and cultural factors 3
• Don't forget to screen for depression and delirium—these are reversible mimics 3
• Don't overlook combined pathology—cerebral atrophy and small vessel disease frequently coexist, especially in Asian populations 4

Documentation of Findings

When communicating diagnostic findings, provide 1:

• Name, characteristics, and severity of the cognitive-behavioral syndrome
• Disease(s) likely causing the syndrome
• Stage of disease
• Prognosis and expected trajectory
• Treatment options and care planning recommendations

This structured approach ensures comprehensive evaluation while maintaining focus on what matters most: the patient's functional abilities and care needs 2.